FDA Approves Omalizumab Injection for Treatment of Food Allergies
The approval was based on positive data from a phase 3 trial that showed patients treated with omalizumab were significantly more likely to tolerate peanut, milk, egg, or cashew protein without moderate to severe allergic symptoms.
Is E-Prescribing the Future of Veterinary Medicine?
Wendy Crouse, DVM, an independent house call veterinarian with Heal House Call Veterinarian, sat down with Drug Topics to discuss how the adoption of e-prescribing has transformed her practice.
What to Expect at Outcomes 2024 SYNC National Conference
Drug Topics sat down with Jude Dieterman, CEO of Outcomes, to discuss the value and uniqueness of the company in the pharmacy market, what’s next on the horizon, and the upcoming event.
The Importance of Continuing Education in Pharmacy Compounding
Kevin Hope, RPh, senior director of pharmacy education at Pharmcon, joined Drug Topics to discuss pharmacy compounding from the new USP changes and the importance of education around compounding best practices.
Heart Attack Linked With Higher Risk of Other Long-Term Health Conditions
After myocardial infarction, all-cause mortality was the most frequent event, followed by heart failure, renal failure, and atrial fibrillation.
FDA Grants Accelerated Approval to Lifileucel, First-Ever Immunotherapy For Unresectable, Metastatic Melanoma
The FDA's decision represents a landmark approval of a tumor-derived cellular therapy in a solid tumor cancer.
2 Commerce Drive Cranbury, NJ 08512